Published in Mol Cell Proteomics on February 04, 2009
The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology (2011) 1.53
Mechanical injury suppresses autophagy regulators and pharmacologic activation of autophagy results in chondroprotection. Arthritis Rheum (2011) 1.38
Effects of short-term glucocorticoid treatment on changes in cartilage matrix degradation and chondrocyte gene expression induced by mechanical injury and inflammatory cytokines. Arthritis Res Ther (2011) 1.19
Comprehensive profiling of cartilage extracellular matrix formation and maturation using sequential extraction and label-free quantitative proteomics. Mol Cell Proteomics (2010) 1.18
The IL-17 family cytokines in immunity and disease. J Clin Immunol (2010) 1.16
Analysing the role of endogenous matrix molecules in the development of osteoarthritis. Int J Exp Pathol (2009) 1.13
A role for TNFα in intervertebral disc degeneration: a non-recoverable catabolic shift. Biochem Biophys Res Commun (2013) 1.08
Synergy between Piezo1 and Piezo2 channels confers high-strain mechanosensitivity to articular cartilage. Proc Natl Acad Sci U S A (2014) 1.03
Strain-dependent oxidant release in articular cartilage originates from mitochondria. Biomech Model Mechanobiol (2013) 0.99
Interleukin-1 beta and tumor necrosis factor alpha inhibit migration activity of chondrogenic progenitor cells from non-fibrillated osteoarthritic cartilage. Arthritis Res Ther (2013) 0.93
Transport of anti-IL-6 antigen binding fragments into cartilage and the effects of injury. Arch Biochem Biophys (2013) 0.84
Effects of doxycycline on mesenchymal stem cell chondrogenesis and cartilage repair. Osteoarthritis Cartilage (2012) 0.81
Use of cartilage derived from murine induced pluripotent stem cells for osteoarthritis drug screening. Arthritis Rheumatol (2014) 0.81
TNFα transport induced by dynamic loading alters biomechanics of intact intervertebral discs. PLoS One (2015) 0.80
Functional imaging in OA: role of imaging in the evaluation of tissue biomechanics. Osteoarthritis Cartilage (2014) 0.79
Changes in chondrocyte gene expression following in vitro impaction of porcine articular cartilage in an impact injury model. J Orthop Res (2012) 0.78
A fragment of the LG3 peptide of endorepellin is present in the urine of physically active mining workers: a potential marker of physical activity. PLoS One (2012) 0.77
Dynamic mechanical compression of devitalized articular cartilage does not activate latent TGF-β. J Biomech (2013) 0.76
Intra-articular dexamethasone to inhibit the development of post-traumatic osteoarthritis. J Orthop Res (2017) 0.76
The chondrogenic response to exercise in the proximal femur of normal and mdx mice. BMC Musculoskelet Disord (2010) 0.76
Mechanosignaling in bone health, trauma and inflammation. Antioxid Redox Signal (2013) 0.76
IL-10 ameliorates TNF-α induced meniscus degeneration in mature meniscal tissue in vitro. BMC Musculoskelet Disord (2017) 0.75
Acidification changes affect the inflammasome in human nucleus pulposus cells. J Inflamm (Lond) (2016) 0.75
Inflammatory conditions partly impair the mechanically mediated activation of Smad2/3 signaling in articular cartilage. Arthritis Res Ther (2016) 0.75
Can the meniscus affect the nature of a chondrocyte? Osteoarthritis Cartilage (2009) 0.75
New developments in the treatment of osteoarthritis - focus on biologic agents. Open Access Rheumatol (2015) 0.75
Cytokine preconditioning of engineered cartilage provides protection against interleukin-1 insult. Arthritis Res Ther (2015) 0.75
Biochemical markers of cartilage metabolism are associated with walking biomechanics 6-months following anterior cruciate ligament reconstruction. J Orthop Res (2017) 0.75
Quantitative proteomics analysis of cartilage response to mechanical injury and cytokine treatment. Matrix Biol (2016) 0.75
Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics (2004) 19.05
TGF-beta signaling and the fibrotic response. FASEB J (2004) 9.81
Making sense of latent TGFbeta activation. J Cell Sci (2003) 8.90
Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature (2005) 5.71
Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev (2003) 5.57
Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol (2002) 3.24
Biosynthetic response of cartilage explants to dynamic compression. J Orthop Res (1989) 2.98
The role of the chondrocyte in osteoarthritis. Arthritis Rheum (2000) 2.87
Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype. J Proteome Res (2006) 2.43
Modulatory effects of sCD14 and LBP on LPS-host cell interactions. J Endotoxin Res (2005) 2.16
The transforming growth factor-beta superfamily of receptors. Cytokine Growth Factor Rev (2004) 2.15
Joint injury causes knee osteoarthritis in young adults. Curr Opin Rheumatol (2005) 2.15
Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum (2006) 2.13
Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis (1990) 2.04
Mechanisms involved in cartilage proteoglycan catabolism. Matrix Biol (2000) 1.99
Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. Mol Cell Proteomics (2007) 1.98
Mechanical injury of cartilage explants causes specific time-dependent changes in chondrocyte gene expression. Arthritis Rheum (2005) 1.94
Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest (1988) 1.89
Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res (2003) 1.79
Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005. Ann Rheum Dis (2005) 1.77
Human peptidoglycan recognition protein-L is an N-acetylmuramoyl-L-alanine amidase. J Biol Chem (2003) 1.74
Injurious mechanical compression of bovine articular cartilage induces chondrocyte apoptosis. Arch Biochem Biophys (2000) 1.73
Articular cartilage repair: are the intrinsic biological constraints undermining this process insuperable? Osteoarthritis Cartilage (1999) 1.69
Intraarticular inflammatory cytokines in acute anterior cruciate ligament injured knee. Knee (2003) 1.69
Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis (2005) 1.66
Molecular pathology and pathobiology of osteoarthritic cartilage. Cell Mol Life Sci (2002) 1.64
Identification of a hyaluronic acid-binding protein that interferes with the preparation of high-buoyant-density proteoglycan aggregates from adult human articular cartilage. Biochem J (1985) 1.62
Basic FGF mediates an immediate response of articular cartilage to mechanical injury. Proc Natl Acad Sci U S A (2002) 1.62
Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines. Arthritis Rheum (2003) 1.59
The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis. Arthritis Rheum (2003) 1.55
The modulation of matrix metalloproteinase and ADAM gene expression in human chondrocytes by interleukin-1 and oncostatin M: a time-course study using real-time quantitative reverse transcription-polymerase chain reaction. Arthritis Rheum (2002) 1.52
Complement deficiency ameliorates collagen-induced arthritis in mice. J Immunol (2002) 1.51
Exuberant expression of chemokine genes by adult human articular chondrocytes in response to IL-1beta. Osteoarthritis Cartilage (2008) 1.49
Biosynthetic response and mechanical properties of articular cartilage after injurious compression. J Orthop Res (2001) 1.47
Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis. Ann Rheum Dis (1994) 1.45
Modulation by interleukin 1 and tumor necrosis factor alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophys Acta (1990) 1.45
Peptidoglycan recognition proteins: on and off switches for innate immunity. Immunol Rev (2004) 1.40
Proteomic analysis of articular cartilage shows increased type II collagen synthesis in osteoarthritis and expression of inhibin betaA (activin A), a regulatory molecule for chondrocytes. J Biol Chem (2004) 1.39
Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA. Biochem Biophys Res Commun (1997) 1.37
Inhibition of cartilage proteoglycan synthesis by interleukin I. Biochem Biophys Res Commun (1988) 1.35
Differential expression of GADD45beta in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes. Arthritis Rheum (2008) 1.33
Aggrecan, aging and assembly in articular cartilage. Cell Mol Life Sci (2005) 1.31
Increased stromelysin-1 (MMP-3), proteoglycan degradation (3B3- and 7D4) and collagen damage in cyclically load-injured articular cartilage. Osteoarthritis Cartilage (2004) 1.29
MMP protein and activity levels in synovial fluid from patients with joint injury, inflammatory arthritis, and osteoarthritis. Ann Rheum Dis (2005) 1.27
Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and skynovial membrane cells from patients with rheumatoid arthritis. Immunology (1980) 1.26
A versatile shear and compression apparatus for mechanical stimulation of tissue culture explants. J Biomech (2000) 1.26
Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Arthritis Rheum (2004) 1.25
Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage. Osteoarthritis Cartilage (2005) 1.24
Compositional and metabolic changes in damaged cartilage are peak-stress, stress-rate, and loading-duration dependent. J Orthop Res (1999) 1.23
Regeneration of defects in articular cartilage in rat knee joints by CCN2 (connective tissue growth factor). J Bone Miner Res (2004) 1.23
Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints. Lab Invest (1996) 1.14
The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor. J Biol Chem (1997) 1.14
Basic fibroblast growth factor mediates transduction of mechanical signals when articular cartilage is loaded. Arthritis Rheum (2004) 1.13
Controlling mesenchymal stem cell differentiation by TGFBeta family members. J Orthop Sci (2003) 1.13
Activin A and follistatin in systemic inflammation. Mol Cell Endocrinol (2004) 1.12
Mechanisms and kinetics of glycosaminoglycan release following in vitro cartilage injury. Arthritis Rheum (2004) 1.11
Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum (2004) 1.10
Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis. Arthritis Res (2000) 1.08
Effects of injurious compression on matrix turnover around individual cells in calf articular cartilage explants. J Orthop Res (1998) 1.07
Molecular basis of osteoarthritis: biomechanical aspects. Cell Mol Life Sci (2002) 1.07
Response of young, aged and osteoarthritic human articular chondrocytes to inflammatory cytokines: molecular and cellular aspects. Matrix Biol (2002) 1.06
G1 domain of aggrecan cointernalizes with hyaluronan via a CD44-mediated mechanism in bovine articular chondrocytes. Arthritis Rheum (2003) 1.05
Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors. Arch Biochem Biophys (1997) 1.05
Identification of the minimal domain structure of bone morphogenetic protein-1 (BMP-1) for chordinase activity: chordinase activity is not enhanced by procollagen C-proteinase enhancer-1 (PCPE-1). J Biol Chem (2005) 1.03
Connective tissue growth factor/CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage. Arthritis Rheum (2006) 1.00
Enhanced expression of insulin-like growth factor-binding proteins in human osteoarthritic cartilage detected by immunohistochemistry and in situ hybridization. Osteoarthritis Cartilage (2005) 0.98
Identification of human semaphorin E gene expression in rheumatoid synovial cells by mRNA differential display. Biochem Biophys Res Commun (1997) 0.96
Induction of interleukin-1 in articular cartilage by explantation and cutting. Arthritis Rheum (2004) 0.96
Recombinant bone morphogenetic protein-4, transforming growth factor-beta 1, and activin A enhance the cartilage phenotype of articular chondrocytes in vitro. Exp Cell Res (1994) 0.94
Nitric oxide enhances aggrecan degradation by aggrecanase in response to TNF-alpha but not IL-1beta treatment at a post-transcriptional level in bovine cartilage explants. Osteoarthritis Cartilage (2007) 0.92
Transcriptional modulation of cartilage-specific collagen gene expression by interferon gamma and tumour necrosis factor alpha in cultured human chondrocytes. Biochem J (1993) 0.92
Comparative plasma proteome analysis of lymphoma-bearing SJL mice. J Proteome Res (2005) 0.90
IL-1beta, but not BMP-7 leads to a dramatic change in the gene expression pattern of human adult articular chondrocytes--portraying the gene expression pattern in two donors. Cytokine (2006) 0.88
Expression of prepro-enkephalin in human articular chondrocytes is linked to cell proliferation. EMBO J (1992) 0.88
Acute injury of the articular cartilage and subchondral bone: a common but unrecognized lesion in the immature knee. AJR Am J Roentgenol (2004) 0.88
Synthesis of insulin-like growth factor binding protein 3 in vitro in human articular cartilage cultures. Arthritis Rheum (2003) 0.86
Collaborative action of M-CSF and CTGF/CCN2 in articular chondrocytes: possible regenerative roles in articular cartilage metabolism. Bone (2005) 0.84
In vivo studies on the effects of human recombinant interleukin-1 beta on articular cartilage. Agents Actions (1989) 0.84
A novel insulin-like growth factor (IGF)-independent role for IGF binding protein-3 in mesenchymal chondroprogenitor cell apoptosis. Endocrinology (2003) 0.84
Automated analytical system for the examination of protein primary structure. Anal Chem (1996) 0.82
Differential regulation of the bone morphogenic protein antagonist chordin in human normal and osteoarthritic chondrocytes. Ann Rheum Dis (2006) 0.82
Physical and biological regulation of proteoglycan turnover around chondrocytes in cartilage explants. Implications for tissue degradation and repair. Ann N Y Acad Sci (1999) 0.78
Distribution of two alternatively spliced variants of the type II collagen N-propeptide compared with the C-propeptide in bovine chondrocyte pellet cultures. J Cell Biochem (1999) 0.77
Proenkephalin A in bone-derived cells. Proc Natl Acad Sci U S A (1991) 0.77
Metalloproteinase production by rabbit articular cartilage: comparison of the effects of interleukin-1 alpha in vitro and in vivo. Virchows Arch (1994) 0.76
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol (2002) 8.37
Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc Natl Acad Sci U S A (2007) 4.80
Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol Cell Proteomics (2005) 4.33
Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proc Natl Acad Sci U S A (2007) 3.63
Effects of HER2 overexpression on cell signaling networks governing proliferation and migration. Mol Syst Biol (2006) 3.01
14-3-3sigma controls mitotic translation to facilitate cytokinesis. Nature (2007) 2.98
Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci U S A (2006) 2.75
A patterned anisotropic nanofluidic sieving structure for continuous-flow separation of DNA and proteins. Nat Nanotechnol (2007) 2.66
Phosphorothioation of DNA in bacteria by dnd genes. Nat Chem Biol (2007) 2.57
The bromodomain protein Brd4 insulates chromatin from DNA damage signalling. Nature (2013) 2.46
Articular cartilage and osteoarthritis. Instr Course Lect (2005) 2.39
Oncogenic EGFR signaling networks in glioma. Sci Signal (2009) 2.38
Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys (2004) 2.24
Sloppy models, parameter uncertainty, and the role of experimental design. Mol Biosyst (2010) 2.12
Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites. J Biol Chem (2002) 2.01
AlkB reverses etheno DNA lesions caused by lipid oxidation in vitro and in vivo. Nat Struct Mol Biol (2005) 1.96
Mechanical injury of cartilage explants causes specific time-dependent changes in chondrocyte gene expression. Arthritis Rheum (2005) 1.94
The hydantoin lesions formed from oxidation of 7,8-dihydro-8-oxoguanine are potent sources of replication errors in vivo. Biochemistry (2003) 1.92
Individual cartilage aggrecan macromolecules and their constituent glycosaminoglycans visualized via atomic force microscopy. J Struct Biol (2003) 1.92
Single dose pharmacokinetics of oral tenofovir in plasma, peripheral blood mononuclear cells, colonic tissue, and vaginal tissue. AIDS Res Hum Retroviruses (2013) 1.76
Stimulus design for model selection and validation in cell signaling. PLoS Comput Biol (2008) 1.75
Modeling HER2 effects on cell behavior from mass spectrometry phosphotyrosine data. PLoS Comput Biol (2006) 1.74
Temporal dynamics of tyrosine phosphorylation in insulin signaling. Diabetes (2006) 1.68
Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer. Proc Natl Acad Sci U S A (2012) 1.67
The rational design of nitric oxide selectivity in single-walled carbon nanotube near-infrared fluorescence sensors for biological detection. Nat Chem (2009) 1.64
Custom design of the cardiac microenvironment with biomaterials. Circ Res (2005) 1.63
Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-MS/MS. J Proteome Res (2006) 1.61
Phosphoproteomic approaches to elucidate cellular signaling networks. Curr Opin Biotechnol (2006) 1.60
Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines. Arthritis Rheum (2003) 1.59
Collecting and organizing systematic sets of protein data. Nat Rev Mol Cell Biol (2006) 1.58
Integration of continuous-flow accelerator mass spectrometry with chromatography and mass-selective detection. Anal Chem (2008) 1.57
Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis. Mol Cell Biol (2009) 1.56
Mechanical compression of cartilage explants induces multiple time-dependent gene expression patterns and involves intracellular calcium and cyclic AMP. J Biol Chem (2004) 1.56
Lipid peroxidation dominates the chemistry of DNA adduct formation in a mouse model of inflammation. Carcinogenesis (2007) 1.55
Quantitative analysis of phosphotyrosine signaling networks triggered by CD3 and CD28 costimulation in Jurkat cells. J Immunol (2006) 1.55
Quantitative phosphoproteomics by mass spectrometry: past, present, and future. Proteomics (2008) 1.50
Oxidation of 7,8-dihydro-8-oxoguanine affords lesions that are potent sources of replication errors in vivo. Biochemistry (2002) 1.48
Global phosphoproteome of HT-29 human colon adenocarcinoma cells. J Proteome Res (2005) 1.46
Combination antibody treatment down-regulates epidermal growth factor receptor by inhibiting endosomal recycling. Proc Natl Acad Sci U S A (2010) 1.46
Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures. J Orthop Res (2008) 1.43
Onset of preclinical osteoarthritis: the angular spatial organization permits early diagnosis. Arthritis Rheum (2011) 1.43
Compressive nanomechanics of opposing aggrecan macromolecules. J Biomech (2005) 1.41
Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: an integrated metagenomics and metabolomics analysis. Environ Health Perspect (2014) 1.41
Influence of tissue maturation and antioxidants on the apoptotic response of articular cartilage after injurious compression. Arthritis Rheum (2004) 1.38
Effects of dynamic compressive loading on chondrocyte biosynthesis in self-assembling peptide scaffolds. J Biomech (2004) 1.37
Gene expression profiles of human chondrocytes during passaged monolayer cultivation. J Orthop Res (2008) 1.36
Pathomechanisms of cartilage destruction by mechanical injury. Ann Anat (2005) 1.31
Large-scale discovery of ERK2 substrates identifies ERK-mediated transcriptional regulation by ETV3. Sci Signal (2011) 1.27
Mechanical injury potentiates proteoglycan catabolism induced by interleukin-6 with soluble interleukin-6 receptor and tumor necrosis factor alpha in immature bovine and adult human articular cartilage. Arthritis Rheum (2009) 1.27
Molecular characterization of EGFR and EGFRvIII signaling networks in human glioblastoma tumor xenografts. Mol Cell Proteomics (2012) 1.25
Three-dimensional head model simulation of transcranial magnetic stimulation. IEEE Trans Biomed Eng (2004) 1.23
PGE2-regulated wnt signaling and N-acetylcysteine are synergistically hepatoprotective in zebrafish acetaminophen injury. Proc Natl Acad Sci U S A (2010) 1.21
Shear and compression differentially regulate clusters of functionally related temporal transcription patterns in cartilage tissue. J Biol Chem (2006) 1.21
CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis. Proc Natl Acad Sci U S A (2011) 1.20
Arylamine exposures and bladder cancer risk. Mutat Res (2002) 1.20
Peroxynitrite-induced oxidation and nitration products of guanine and 8-oxoguanine: structures and mechanisms of product formation. Nitric Oxide (2005) 1.19
Tapasin is a facilitator, not an editor, of class I MHC peptide binding. J Immunol (2003) 1.19
Mechanical regulation of mitogen-activated protein kinase signaling in articular cartilage. J Biol Chem (2003) 1.19
Effects of short-term glucocorticoid treatment on changes in cartilage matrix degradation and chondrocyte gene expression induced by mechanical injury and inflammatory cytokines. Arthritis Res Ther (2011) 1.19
Phosphoproteomics: unraveling the signaling web. Mol Cell (2008) 1.18
An interface for direct analysis of (14)c in nonvolatile samples by accelerator mass spectrometry. Anal Chem (2004) 1.18
Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. Am J Pathol (2004) 1.18
Liver tissue engineering in the evaluation of drug safety. Expert Opin Drug Metab Toxicol (2009) 1.17
Manual validation of peptide sequence and sites of tyrosine phosphorylation from MS/MS spectra. Methods Mol Biol (2009) 1.16
Analysis of MHC class II antigen processing by quantitation of peptides that constitute nested sets. J Immunol (2002) 1.16
Shear- and compression-induced chondrocyte transcription requires MAPK activation in cartilage explants. J Biol Chem (2007) 1.15
S-Nitrosation regulates the activation of endogenous procaspase-9 in HT-29 human colon carcinoma cells. J Biol Chem (2003) 1.15
Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF. PLoS Negl Trop Dis (2012) 1.14
Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer. J Natl Cancer Inst (2004) 1.14
PTMScout, a Web resource for analysis of high throughput post-translational proteomics studies. Mol Cell Proteomics (2010) 1.13
Mechanisms and kinetics of glycosaminoglycan release following in vitro cartilage injury. Arthritis Rheum (2004) 1.11
Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth. Mol Biosyst (2010) 1.11
Increase of reaction rate and sensitivity of low-abundance enzyme assay using micro/nanofluidic preconcentration chip. Anal Chem (2008) 1.11
Nonsmoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol Biomarkers Prev (2003) 1.09
Transport and binding of insulin-like growth factor I through articular cartilage. Arch Biochem Biophys (2003) 1.09
Lateral nanomechanics of cartilage aggrecan macromolecules. Biophys J (2006) 1.08
Evaluation of medium supplemented with insulin-transferrin-selenium for culture of primary bovine calf chondrocytes in three-dimensional hydrogel scaffolds. Tissue Eng (2005) 1.08
Modulation of lubricin biosynthesis and tissue surface properties following cartilage mechanical injury. Arthritis Rheum (2009) 1.08
Chondrocyte mechanotransduction: effects of compression on deformation of intracellular organelles and relevance to cellular biosynthesis. Osteoarthritis Cartilage (2004) 1.08
Uncovering therapeutic targets for glioblastoma: a systems biology approach. Cell Cycle (2007) 1.07
Time-dependent nanomechanics of cartilage. Biophys J (2011) 1.07
Dynamic compression stimulates proteoglycan synthesis by mesenchymal stem cells in the absence of chondrogenic cytokines. Tissue Eng Part A (2009) 1.05
Spiroiminodihydantoin and guanidinohydantoin are the dominant products of 8-oxoguanosine oxidation at low fluxes of peroxynitrite: mechanistic studies with 18O. Chem Res Toxicol (2004) 1.04
Quantitation of four guanine oxidation products from reaction of DNA with varying doses of peroxynitrite. Chem Res Toxicol (2005) 1.04
Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res (2007) 1.04
Gut microbiome perturbations induced by bacterial infection affect arsenic biotransformation. Chem Res Toxicol (2013) 1.04
A coarse-grained molecular model for glycosaminoglycans: application to chondroitin, chondroitin sulfate, and hyaluronic acid. Biophys J (2005) 1.02
Covalent adducts arising from the decomposition products of lipid hydroperoxides in the presence of cytochrome c. Chem Res Toxicol (2007) 1.01